World Malaria Report 2023: “We are at the crossroads of opportunities and challenges,” says WHO 30 November 2023
Africa-Europe partnership launches study to evaluate emergency response tools for severe malaria in highly isolated rural settings 27 November 2023
Countries can hold the line against antimalarial resistance in Africa - but we must act now 13 November 2023
First African-manufactured combination therapy for seasonal malaria chemoprevention receives WHO prequalification 6 November 2023 Universal Corporation Ltd (UCL), a Strides Pharma Science Limited (Strides) enterprise, with support from MMV, has become the first African manufacturer to gain WHO prequalification for their sulfadoxine-pyrimethamine + amodiaquine product.
Enabling supply continuity by strengthening local manufacturing in Africa 30 October 2023 This report provides an overview of how MMV has been supporting African manufacturers to produce quality-assured antimalarial therapies.
Community Health Workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries 20 October 2023 Int J Infect Dis
MMV at a glance: introductory brochure 2023 4 October 2023 MMV at a glance is an introductory brochure sharing MMV's mission and highlighting our unique partnership model, the growth of our portfolio and the increasing impact of our access work.
Britain and beyond: achieving a stronger, safer world through malaria eradication 2 October 2023 A report from Zero Malaria Britain outlining how malaria threatens global health security and Britain's role in eradicating the disease.
7 MMV funded scholars will start their training at the Malaria Research and Training Center, Mali 2 October 2023
Can malaria researchers slow the spread of drug resistance? 22 September 2023 Concerns that artemisinin combination treatments are losing their effectiveness against Plasmodium parasites have set scientists looking for alternatives.
Using Cryopreserved Plasmodium falciparum Sporozoites in a Humanized Mouse Model to Study Early Malaria Infection Processes and Test Prophylactic Treatments 31 August 2023
SMC and RTS,S vaccine in combination show considerable advantage in preventing malaria 31 August 2023
Brazil becomes the first malaria-endemic country to register single-dose tafenoquine for children with relapsing malaria 21 August 2023
Development and application of a PBPK modeling strategy to support antimalarial drug development 15 August 2023 CPT Pharmacometrics Syst Pharmacol
